Altered irinotecan metabolism in a patient receiving phenytoin
作者:
Ron Mathijssen,
Alex Sparreboom,
Herlinde Dumez,
Allan van Oosterom,
Ernst de Bruijn,
期刊:
Anti-Cancer Drugs
(OVID Available online 2002)
卷期:
Volume 13,
issue 2
页码: 139-140
ISSN:0959-4973
年代: 2002
出版商: OVID
关键词: Irinotecan;metabolism;phenytoin
数据来源: OVID
摘要:
The systemic exposure to the anticancer agent irinotecan (CPT-11) and its active metabolite SN-38 were 79 and 92% reduced, respectively, relative to literature data, by concomitant phenytoin therapy. This finding suggests that increased doses of CPT-11 should be given to patients treated simultaneously with these drugs, to achieve adequate levels of SN-38.
点击下载:
PDF
(57KB)
返 回